[ad_1]
Reata Pharmaceuticals RETA reported its Q2 earnings results on Monday, August 8, 2022 at 08:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Reata Pharmaceuticals beat estimated earnings by 32.67%, reporting an EPS of $-1.36 versus an estimate of $-2.02.
Revenue was down $1.46 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.82 which was followed by a 7.0% drop in the share price the next day.
Here’s a look at Reata Pharmaceuticals’s past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | -2.15 | -2.31 | -2.16 | -2.08 |
EPS Actual | -1.33 | -1.59 | -1.27 | -1.32 |
Revenue Estimate | 1.55M | 1.63M | 2.07M | 1.25M |
Revenue Actual | 914K | 934K | 7.39M | 2.22M |
To track all earnings releases for Reata Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
[ad_2]
Image and article originally from www.benzinga.com. Read the original article here.